Fullerene isoniazid conjugate - A tuberculostat with increased lipophilicity: Synthesis and evaluation of antimycobacterial activity

Chemical Biology and Drug Design

Volumn 73, Issue 5, 2009, Pages 553-557

  Kumar, Anish ^a   Patel, Gaurang ^a   Menon, Shobhana Karuveettil ^a  

^a GUJARAT UNIVERSITY   (India)

Author keywords

Antimycobacterial; Drug design; Fulleropyrrolidine; Isoniazid; Nanotechnology (drug discovery)

Indexed keywords

ANTIMYCOBACTERIAL AGENT; FULLERENE DERIVATIVE; FULLERENE ISONIAZID DERIVATIVE; ISONIAZID DERIVATIVE; ISONICOTINIC ACID; ISONICOTINIC ACID (4 FORMYLBENZYLIDENE)HYDRAZIDE; NANOPARTICLE; SARCOSINE; TUBERCULOSTATIC AGENT; UNCLASSIFIED DRUG;

ANTIBACTERIAL ACTIVITY; ARTICLE; CARBON NUCLEAR MAGNETIC RESONANCE; CYCLOADDITION; DRUG CONJUGATION; DRUG DESIGN; DRUG SCREENING; DRUG SYNTHESIS; LIPOPHILICITY; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; MINIMUM INHIBITORY CONCENTRATION; MYCOBACTERIUM AVIUM; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; PARTICLE SIZE; PRIORITY JOURNAL; PROTON NUCLEAR MAGNETIC RESONANCE; TRANSMISSION ELECTRON MICROSCOPY;

ANTITUBERCULAR AGENTS; CYCLIZATION; FULLERENES; ISONIAZID; MICROBIAL SENSITIVITY TESTS; MICROSCOPY, ELECTRON, TRANSMISSION; MYCOBACTERIUM AVIUM;

MYCOBACTERIUM AVIUM; MYCOBACTERIUM TUBERCULOSIS H37RV;

EID: 64249115885     PISSN: 17470277     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1747-0285.2009.00804.x     Document Type: Article

References (20)

1. American Society for Microbiology (1995) Report of the ASM task force on antibiotic resistance. Antimicrob Agents Chemother 39 (Suppl. 1 1 23.
2. World Health Organization (1994) TB: A Global Emergency WHO Report No. 14977. Geneva, Switzerland : WHO.
3. Ragno R., Marshall G.R., Di Santo R., Costi R., Massa S., Pompei R., Artico M. (2000) Antimycobacterial pyrroles: synthesis, anti-mycobacterium tuberculosis activity and QSAR studies. Bioorg Med Chem 8 : 1423 1432.
4. Troshin P.A., Lyubovskaya R.N. (2008) Organic chemistry of fullerenes: the major reactions, type of fullerene derivatives and prospects for their practical use. Russ Chem Rev 77 : 305 349.
5. Bosi S., Ros T.D., Spalluto G., Prato M. (2003) Fullerenes: an attractive tool for biological applications. Eur J Med Chem 38 : 913 923.
6. Kumar A., Menon S.K. (2008) Fullerene derivatized s-triazine analogues as antimicrobial agents. Eur J Med Chem DOI :.
7. Wilson L.J. (2004) US Patent 241, 173.
8. Mandell G.L., Sande M.A. (1984 8th edn. In : Mandell G.L., Sande M.A. editors. Goodman and Gilman's - The Pharmacological Basis of Therapeutics. New York : Pergamon Press p. 1147 1178.
9. Sherman D.R., Mdluli K., Hickey M.J., Arain T.M., Morris S.L., Barry C.E. III., Kendall Stover C. (1996) Compensatory ahpC gene expression in isoniazid-resistant Mycobacterium tuberculosis. Science 272 : 1641 1643.
10. Augustynowicz-Kopec E., Zwolska Z. (2000) Bioavailability factors of isoniazid in fast and slow acetylators, healthy volunteers. Acta Pol Pharm 59 : 452 457.
11. Augustynowicz-Kopec E., Zwolska Z. (2000) The type of isoniazid acetylation in tuberculosis patients treated at national tuberculosis and lung diseases research institute. Acta Pol Pharm 59 : 443 447.
12. Cocco M.T., Congui C., Onnis V., Pussedo M.C., Schivo M.L., Logu A. (1999) Synthesis and antimycobacterial activity of some isonicotinoylhydrazones. Eur J Med Chem 34 : 1071 1076.
13. Lambert P.A. (2002) Cellular impermeability and uptake of biocides and antibiotics in gram-positive bacteria and mycobacteria. J Appl Microbiol 92 (Suppl. 46S 54S.
14. Hearn M.J., Cynamon M.H. (2004) Design and synthesis of antituberculars: preparation and evaluation against mycobacterium tuberculosis of an isoniazid Schiff base. J Antimicrob Chem 53 : 185 191.
15. Bosi S., Ros T.D., Castellano S., Bunfi E., Prato M. (2000) Antimycobacterial activity of ionic fullerene derivatives. Bioorg Med Chem Lett 10 : 1043 1045.
16. 60. J Org Chem 61 : 9070 9072.
17. Lyon D.Y., Adams L.K., Falkner T.C., Alvarez P.L. (2006) Antibacterial activity of fullerene water suspensions: effects of preparation methods and particle size. Environ Sci Technol 40 : 4360 4366.
18. Heifets L.B. (1991) Drug susceptibility test in management of chemotherapy of tuberculosis. In : Heifets L.B., editor. Drug Susceptibility in the Chemotherapy of Mycobacterial Infections. Boca Raton, FL : CRC Press Inc p. 89 122.
19. Inderleid C.B., Salfinger M. (1995) Antimycobacterial agents and susceptibility tests mycobacteria, 6th edn. In : Murray P.R., Baron E.J., Pfaller M.A., Tenover F.C., Yolken R.H., editors. Manual of Clinical Microbiology. Washington, DC : ASM press p. 1385 1404.
20. Ghose A.K., Vishwanadhan V.N., Wendoloski J.J. (1998) Prediction of hydrophobic (lipophilic) properties of small organic molecules using fragmental methods: an analysis of ALOGP and CLOGP methods. J Phy Chem 102 : 3762 3772.